NEW CRITERIA TO IDENTIFY RISK OF PROGRESSION IN MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE AND SMOLDERING MULTIPLE MYELOMA BASED ON MULTIPARAMETER FLOW CYTOMETRY ANALYSIS OF BONE MARROW PLASMA CELLS RUNNING HEAD: PROGRESSION CRITERIA IN MGUS and SMOLDERING MULTIPLE MYELOMA AUTHORS:
نویسندگان
چکیده
AUTHORS: Ernesto Pérez-Persona, MD; María-Belén Vidriales, MD, PhD; Gema Mateo, PhD; Ramón García-Sanz, MD, PhD; Maria-Victoria Mateos, MD, PhD; Alfonso García de Coca, MD; Josefina Galende, MD, PhD; Guillermo Martín-Nuñez, MD, PhD; José M Alonso, MD; Natalia de las Heras, MD, PhD; José M Hernández, MD, PhD; Alejandro Martín, MD, PhD; Consuelo López-Berges, MD, PhD; Alberto Orfao, MD, PhD; Jesús F. San Miguel, MD, PhD.
منابع مشابه
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
Monoclonal gammopathy of uncertain significance (MGUS) and smoldering multiple myeloma (SMM) are plasma cell disorders with a risk of progression of approximately 1% and 10% per year, respectively. We have previously shown that the proportion of bone marrow (BM) aberrant plasma cells (aPCs) within the BMPC compartment (aPC/BMPC) as assessed by flow cytometry (FC) contributes to differential dia...
متن کاملManagement of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Monoclonal gammopathy of undetermined significance (MGUS) is defined as a serum M protein level of less than 3 g/dL, less than 10% clonal plasma cells in the bone marrow, and the absence of end-organ damage. The prevalence of MGUS is 3.2% in the white population but is approximately twice that high in the black population. MGUS may progress to multiple myeloma, AL amyloidosis, Waldenström macro...
متن کاملMonoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Monoclonal gammopathy of undetermined significance (MGUS) is characterized by the presence of a serum monoclonal (M) protein level less than 3 g/dL, less than 10% clonal plasma cells in the bone marrow, and the absence of hypercalcemia, renal insufficiency, anemia, or bone lesions attributable to a clonal plasma cell disorder. Patients may be tested for a monoclonal gammopathy by serum protein ...
متن کاملReview Series MULTIPLE MYELOMA: FROM THE BENCH TO BEDSIDE Smoldering multiple myeloma
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell (PC) disorder. Kyle and Greipp initially described the entity as an intermediate stage between monoclonal gammopathy of undermined significance (MGUS) andmultiplemyeloma (MM) on the basis of 6 patients with increased bone marrow PCs ($10%) who remained stable for$5 years without chemotherapy. SMM has since beenwell characte...
متن کاملMGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic, pre-malignant disorders characterized by monoclonal plasma cell proliferation in the bone marrow and absence of end-organ damage. Recent advances in the pathogenesis, natural history, and prognosis of MGUS and SMM are reviewed. A new risk stratification system to determine the progn...
متن کامل